Clinical investigations of dengue patients have assessed varying timeframes of IFN kinetics and levels during infection, e.g., higher IFN-α levels were identified in the period comprising the early acute phase (0 to 3 days after fever onset) (54, 60), but also throughout the acute phase (57). This evidence concerns the gene IFNA1 and dengue disease.